<![CDATA[지앤티파마 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=34372>Sun, 03 May 2026 21:28:12 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[GNT Pharma’s GedaCure® Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome]]>https://www.newswire.co.kr/newsRead.php?no=918524Mon, 15 Feb 2021 09:47:28 +0900<![CDATA[GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy]]>https://www.newswire.co.kr/newsRead.php?no=912213Thu, 15 Oct 2020 11:54:27 +0900<![CDATA[GNT Pharma‘s Anti-dementia Drug ’crisdesalazine' Demonstrates Efficacy in Phase III Clinical Study with Companion Dogs with Dementia]]>https://www.newswire.co.kr/newsRead.php?no=900031Wed, 15 Jan 2020 09:06:43 +0900